Free Trial
→ Elon’s Biggest Launch Ever: 15x Bigger Than SpaceX (From InvestorPlace) (Ad)tc pixel Free PTIXW Stock Alerts

Protagenic Therapeutics (PTIXW) Competitors

$0.0035 0.00 (0.00%)
As of 04/24/2026
Compare

PTIXW vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

Should you be buying Protagenic Therapeutics stock or one of its competitors? The main competitors of Protagenic Therapeutics include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

How does Protagenic Therapeutics compare to Ainos?

Protagenic Therapeutics (NASDAQ:PTIXW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

In the previous week, Protagenic Therapeutics' average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
Protagenic Therapeutics Neutral
Ainos Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protagenic TherapeuticsN/AN/AN/AN/AN/A
Ainos$124.16KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Protagenic TherapeuticsN/A N/A N/A
Ainos N/A N/A N/A

Summary

Ainos beats Protagenic Therapeutics on 1 of the 1 factors compared between the two stocks.

How does Protagenic Therapeutics compare to Alvotech?

Protagenic Therapeutics (NASDAQ:PTIXW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protagenic TherapeuticsN/AN/AN/AN/AN/A
Alvotech$586.32MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Protagenic TherapeuticsN/A N/A N/A
Alvotech N/A N/A N/A

In the previous week, Protagenic Therapeutics' average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
Protagenic Therapeutics Neutral
Alvotech Neutral

Summary

Alvotech beats Protagenic Therapeutics on 1 of the 1 factors compared between the two stocks.

How does Protagenic Therapeutics compare to Aravive?

Protagenic Therapeutics (NASDAQ:PTIXW) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

In the previous week, Protagenic Therapeutics' average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
Protagenic Therapeutics Neutral
Aravive Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protagenic TherapeuticsN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

Company Net Margins Return on Equity Return on Assets
Protagenic TherapeuticsN/A N/A N/A
Aravive N/A N/A N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Aravive beats Protagenic Therapeutics on 2 of the 2 factors compared between the two stocks.

How does Protagenic Therapeutics compare to Atlantic Coastal Acquisition Corp. II?

Protagenic Therapeutics (NASDAQ:PTIXW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protagenic TherapeuticsN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Protagenic TherapeuticsN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

In the previous week, Protagenic Therapeutics' average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
Protagenic Therapeutics Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Summary

Protagenic Therapeutics and Atlantic Coastal Acquisition Corp. II tied by winning 0 of the 0 factors compared between the two stocks.

How does Protagenic Therapeutics compare to Avidity Biosciences?

Protagenic Therapeutics (NASDAQ:PTIXW) and Avidity Biosciences (NASDAQ:RNA) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Protagenic Therapeutics has higher earnings, but lower revenue than Avidity Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protagenic TherapeuticsN/AN/AN/AN/AN/A
Avidity Biosciences$18.62MN/A-$322.30MN/AN/A

Protagenic Therapeutics has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Protagenic Therapeutics' return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Protagenic TherapeuticsN/A N/A N/A
Avidity Biosciences -3,650.39%-44.92%-39.57%

In the previous week, Avidity Biosciences had 1 more articles in the media than Protagenic Therapeutics. MarketBeat recorded 1 mentions for Avidity Biosciences and 0 mentions for Protagenic Therapeutics. Protagenic Therapeutics' average media sentiment score of 0.00 equaled Avidity Biosciences'average media sentiment score.

Company Overall Sentiment
Protagenic Therapeutics Neutral
Avidity Biosciences Neutral

Avidity Biosciences has a consensus price target of $69.42, indicating a potential upside of 428.72%. Given Avidity Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Avidity Biosciences is more favorable than Protagenic Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Protagenic Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Avidity Biosciences
1 Sell rating(s)
12 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.32

Summary

Avidity Biosciences beats Protagenic Therapeutics on 6 of the 9 factors compared between the two stocks.

Get Protagenic Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTIXW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PTIXW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PTIXW vs. The Competition

Export
MetricProtagenic TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$449.52M$6.27B$12.02B
Dividend YieldN/A3.86%2.74%5.26%
P/E RatioN/A4.1729.1127.10
Price / SalesN/A6,716.94500.5873.99
Price / CashN/A13.1343.3053.90
Price / BookN/A78.669.666.70
Net IncomeN/A-$96.07M$3.54B$332.64M
7 Day PerformanceN/A1.16%3.14%3.50%
1 Month PerformanceN/A3.56%5.27%8.31%
1 Year PerformanceN/A49.00%38.71%42.31%

Protagenic Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PTIXW
Protagenic Therapeutics
N/A$0.00
flat		N/AN/A$0.00N/AN/A2
AIMDW
Ainos
N/A$0.11
flat		N/A-65.4%$0.00$124.16KN/A40
ALVOW
Alvotech
N/A$0.21
-18.2%		N/AN/A$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:PTIXW) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners
A U.S. Resource Gap Is a National Issue - and Opportunity
America still does not domestically produce one mineral tied to batteries, energy storage, and national defens...
i2i Marketing Group, LLC | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
Trump and Elon are BACK
15X Bigger Than SpaceX: Elon's New Launch While the rest of the market goes crazy for "the mother of all IP...
InvestorPlace | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel
Revealed: The World’s First Trillion-Dollar Robot
Jensen Huang stood in Las Vegas and laid out Nvidia's vision for building the world's first trillion-dollar ro...
Weiss Ratings | Sponsoredtc pixel